DNA Damage/DNA Repair
Research Areas
- MTH1(4)
- PARP(103)
- ATM/ATR(31)
- DNA Alkylating(23)
- DNA Ligases(3)
- DNA Methyltransferase(27)
- DNA-PK(28)
- HDAC(143)
- Nucleoside Antimetabolite/Analogue(194)
- Telomerase(15)
- Topoisomerase(193)
- tankyrase(5)
- Antifolate(33)
- CDK(299)
- Checkpoint Kinase (Chk)(36)
- CRISPR/Cas9(9)
- Deubiquitinase(84)
- DNA Alkylator/Crosslinker(87)
- DNA/RNA Synthesis(575)
- Eukaryotic Initiation Factor (eIF)(33)
- IRE1(25)
- LIM Kinase (LIMK)(12)
- TOPK(6)
- Casein Kinase(59)
- DNA Intercalating Agents(8)
- DNA/RNA Oxidative Damage(13)
- Poly(ADP-ribose) Glycohydrolase (PARG)(5)
- Early 2 Factor (E2F)(2)
- Zinc Finger Protein(1)
Products Related to DNA Damage/DNA Repair(1968)
- GC79041Tofersen scrambled controlPurity: >96.00%
Tofersen scrambled control is a scrambled control antisense oligonucleotide of Tofersen with a scrambled sequence in the target binding region.
- GC79042ASO 556089 (with PS modification) sodiumPurity: >98.00%
ASO 556089 (with PS modification) sodium is the PS-modified version of ASO 556089.
- GC79046HDAC-IN-98CAS: 3124773-51-6Purity: >98.00%
HDAC-IN-98 is a HDAC1, HDAC2, HDAC3 inhibitor (one of the most selective class I HDAC inhibitors) with human IC 50 values of 41.2 nM, 52.5 nM, and 74.3 nM respectively.
- GC79047HDAC6-IN-75CAS: 400078-78-6Purity: >99.50%
HDAC6-IN-75 is a selective HDAC6 inhibitor with an IC 50 of 0.17 nM against HDAC6.
- GC79048HDAC1/3-IN-1CAS: 244289-53-0Purity: >99.50%
HDAC1/3-IN-1 is a selective HDAC1/3 inhibitor, with IC 50 values of 256 nM and 340.3 nM against HDAC1 and HDAC3, respectively.
- GC79051HDAC6-IN-85CAS: 948837-73-8Purity: >97.50%
HDAC6-IN-85 is a selective HDAC6 inhibitor, with pIC 50 values of 5.4, 5.5, 5.9, and 4.8 against rHDAC1, rHDAC3, rHDAC6, and rHDAC8, respectively.
- GC79055HDAC11-IN-4Purity: >95.00%
HDAC11-IN-4 is a potent and selective HDAC11 inhibitor with an IC 50 of 13.49 nM and a K i of 2.2 nM.
- GC79058PARP1/NAMPT-IN-1CAS: 3084810-86-3Purity: >98.00%
PARP1/NAMPT-IN-1 is a potent and dual PARP1 and NAMPT inhibitor with IC 50 values of 1.2 nM and 6.7 nM, respectively.
- GC79059SAP15 acetatePurity: >98.00%
SAP15 (Synthetic anti-inflammatory peptide 15) acetate is a synthetic anti-inflammatory peptide consisting of 15 amino acids designed from human beta-defensin 3.
- GC79061PARP1-IN-56CAS: 1574367-80-8Purity: >99.00%
PARP1-IN-56 (Compound RCY) is an I-labeled poly(ADP−ribose) polymerase ( PARP1 ) inhibitor.
- GC79067ADAR1i-124Purity: >98.50%
ADAR1i-124 is an A-to-I RNA editing inhibitor by inhibiting the catalytic activities of both ADAR1p150 and ADAR1p110.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC79040 | NERx 329 | 2649242-85-1 | >98.50% | |
NERx 329 is a replication protein A ( RPA ) inhibitor with an IC 50 of 4.9 μM. | ||||
| GC79041 | Tofersen scrambled control | - | >96.00% | |
Tofersen scrambled control is a scrambled control antisense oligonucleotide of Tofersen with a scrambled sequence in the target binding region. | ||||
| GC79042 | ASO 556089 (with PS modification) sodium | - | >98.00% | |
ASO 556089 (with PS modification) sodium is the PS-modified version of ASO 556089. | ||||
| GC79046 | HDAC-IN-98 | 3124773-51-6 | >98.00% | |
HDAC-IN-98 is a HDAC1, HDAC2, HDAC3 inhibitor (one of the most selective class I HDAC inhibitors) with human IC 50 values of 41.2 nM, 52.5 nM, and 74.3 nM respectively. | ||||
| GC79047 | HDAC6-IN-75 | 400078-78-6 | >99.50% | |
HDAC6-IN-75 is a selective HDAC6 inhibitor with an IC 50 of 0.17 nM against HDAC6. | ||||
| GC79048 | HDAC1/3-IN-1 | 244289-53-0 | >99.50% | |
HDAC1/3-IN-1 is a selective HDAC1/3 inhibitor, with IC 50 values of 256 nM and 340.3 nM against HDAC1 and HDAC3, respectively. | ||||
| GC79049 | CG-1521 | 674767-29-4 | >95.50% | |
CG-1521 is a histone deacetylase ( HDAC ) inhibitor that stabilizes Ac-Lys373 P53, increases P21 levels and HDAC2 degradation. | ||||
| GC79050 | OUL312 | - | >99.00% | |
OUL312 is a potent PARP10 inhibitor ( IC 50 = 20 nM), showing more than 75-fold greater selectivity for PARP15 ( IC 50 = 1500 nM). | ||||
| GC79051 | HDAC6-IN-85 | 948837-73-8 | >97.50% | |
HDAC6-IN-85 is a selective HDAC6 inhibitor, with pIC 50 values of 5.4, 5.5, 5.9, and 4.8 against rHDAC1, rHDAC3, rHDAC6, and rHDAC8, respectively. | ||||
| GC79052 | HDAC10-IN-3 formic | - | >97.00% | |
| GC79053 | G194-0712 | 1029737-28-7 | >99.50% | |
G194-0712 is a selective histone deacetylase 5 ( HDAC5 ) activator with an EC 50 of 7.96 μM and a K d of 2.53 μM. | ||||
| GC79054 | PTER-IN-1 | 3114432-21-9 | >98.00% | |
PTERi is a selective inhibitor of PTER with selectivity towards HDACs. | ||||
| GC79055 | HDAC11-IN-4 | - | >95.00% | |
HDAC11-IN-4 is a potent and selective HDAC11 inhibitor with an IC 50 of 13.49 nM and a K i of 2.2 nM. | ||||
| GC79056 | KMR-206 | 2992741-10-1 | >99.50% | |
KMR-206 is a PARP7 inhibitor with an IC 50 of 13.7 nM. | ||||
| GC79058 | PARP1/NAMPT-IN-1 | 3084810-86-3 | >98.00% | |
PARP1/NAMPT-IN-1 is a potent and dual PARP1 and NAMPT inhibitor with IC 50 values of 1.2 nM and 6.7 nM, respectively. | ||||
| GC79059 | SAP15 acetate | - | >98.00% | |
SAP15 (Synthetic anti-inflammatory peptide 15) acetate is a synthetic anti-inflammatory peptide consisting of 15 amino acids designed from human beta-defensin 3. | ||||
| GC79060 | A-620223 | 272769-49-0 | >96.00% | |
A-620223 is a PARP-1 inhibitor with a K i of 8 nM against PARP-1 and EC 50 of 3 nM in a whole cell assay. | ||||
| GC79061 | PARP1-IN-56 | 1574367-80-8 | >99.00% | |
PARP1-IN-56 (Compound RCY) is an I-labeled poly(ADP−ribose) polymerase ( PARP1 ) inhibitor. | ||||
| GC79062 | PCIP-1 | - | >98.50% | |
PCIP-1 is a PARP2 inhibitor. | ||||
| GC79063 | TNKS-IN-1 | 59455-93-5 | >99.50% | |
TNKS-IN-1 is a selective and potent tankyrase ( TNKS1 / TNKS2 ) inhibitor with IC 50 values of 7.9 nM and 8.7 nM. | ||||
| GC79064 | VT00065 | 144163-68-8 | >98.00% | |
VT00065 is a covalent DHS inhibitor. | ||||
| GC79065 | NVS2.1 | 1831092-94-4 | >99.50% | |
NVS2.1 is a potent, orally active and brain-penetrant readthrough promoter. | ||||
| GC79066 | APL-4098 | 2752441-61-3 | >99.50% | |
APL-4098 is an orally active, selective, ATP-competitive GCN2 inhibitor with a K i of 4.39 nM and a K d of 2.9 nM. | ||||
| GC79067 | ADAR1i-124 | - | >98.50% | |
ADAR1i-124 is an A-to-I RNA editing inhibitor by inhibiting the catalytic activities of both ADAR1p150 and ADAR1p110. | ||||
